R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2021
Back to search
Official data from USPTO
GFGLENHER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
11/02/2021
Trademark type
Combined
Nice classes
5
Filing date
04/07/2020
Registration date
11/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/02/2021
Last transaction
11/02/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Seoul, KR
Examiner
STINSON,JENNIFER ELLE
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "GFGLENHER" in stylized capital letters.
Holders and representatives
Holders
G+FLAS LIFE SCIENCES
Representatives
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for use in veterinary genetic testing for medical use; Diagnostic preparations for veterinary purposes; Pharmaceutical preparations for gene therapygene editinggenome editing; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Protein arrays for medical diagnosis purposes; Ferments for medical or veterinary use; Biological preparations for the treatment of breast cancer; Nutritive substances for microorganisms for medical purposes; Therapeutic pharmaceutical for the treatment of breast cancer; Reagents for medical use; Diagnostic preparations for medical purposes for detecting mutations in genes; Stem cells for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for treating breast cancer; Therapeutic pharmaceutical for the treatment of rare genetic disorder
Publications
History of USPTO decisions and trademark events.
18 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2021
PUBO
PUBLISHED FOR OPPOSITION
08/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2021
ALIE
ASSIGNED TO LIE
06/17/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/02/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/04/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/04/2021
CNSI
SUSPENSION INQUIRY WRITTEN
01/04/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/26/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/26/2020
CNSL
SUSPENSION LETTER WRITTEN
06/26/2020
DOCK
ASSIGNED TO EXAMINER
06/25/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/14/2020
NWAP
NEW APPLICATION ENTERED
04/10/2020
Continuous trademark protection
Get notified about every new filing that threatens GFGLENHER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.